Cargando…

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment

OBJECTIVE: To determine if continuous subcutaneous insulin infusion (CSII) therapy is associated with lower glycated haemoglobin (HbA1c) variability (long-term glycaemic variability; GV) relative to multiple daily injection (MDI) treatment in adults with type 1 diabetes mellitus (T1DM). DESIGN: Retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Emma S, McGrath, Rachel T, Januszewski, Andrzej S, Calandro, Daniel, Hardikar, Anandwardhan A, O'Neal, David N, Fulcher, Gregory, Jenkins, Alicia J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937034/ https://www.ncbi.nlm.nih.gov/pubmed/31888933 http://dx.doi.org/10.1136/bmjopen-2019-033059

Ejemplares similares

Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
por: Scott, Emma S., et al.
Publicado: (2021)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Drug titration patterns and HbA(1c) levels in type 2 diabetes
por: Ross Maclean, J, et al.
Publicado: (2009)

SAT152 Retrospective Analysis Of HbA1c In Patients Diagnosed With Pancreatic Insulinoma Prior To- And After Surgical Excision
por: Lawless, Sarah Jean, et al.
Publicado: (2023)

RT‐CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta‐analysis
por: William, Jimmy, et al.
Publicado: (2022)

Postnatal growth of infants with neonatal diabetes: Insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy
por: Alyafie, Fawzia, et al.
Publicado: (2019)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Glycated Haemoglobin (HbA1c) Variations in Nondiabetics With Nutritional Anemia
por: Pilla, Rakesh, et al.
Publicado: (2020)

Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
por: Li, Feng-fei, et al.
Publicado: (2018)

Development and validation of an instrument (CSII – Brazil) to assess users’ conceptual and procedural knowledge of continuous subcutaneous infusion systems
por: Amaral, Camilla Magalhães de Oliveira, et al.
Publicado: (2020)

GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice
por: Furler, John, et al.
Publicado: (2018)

Effects of Treatment With Continuous Subcutaneous Insulin Infusion on Arterial Stiffness and Endothelial Glycocalyx Compared to MDI Intensification in Patients With Type 1 Diabetes: Improvement After a Six-Month Pump Treatment
por: Kountouri, Aikaterini, et al.
Publicado: (2021)

The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes
por: Katwal, Prakash C, et al.
Publicado: (2020)

The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy
por: Almutairi, Noura M, et al.
Publicado: (2021)

ODP169 Challenges with use of HbA1C for Evaluation of Blood Glucose Control
por: Maletkovic, Jelena
Publicado: (2022)

THU253 The Hemoglobin Wayne Variant And Association With Falsely Elevated HbA1c
por: Mulpuri, Neha, et al.
Publicado: (2023)

Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
por: Hu, Sicui, et al.
Publicado: (2021)

Association Between Raised HbA1c Levels and Hemorrhagic Transformation in Patients With Ischemic Stroke
por: Afzal, Benish, et al.
Publicado: (2021)

Assessment of Glycemic Control in Patients With Diabetes in Northern Sudan Using Calculated HbA1c
por: Abdel bagi, Omer, et al.
Publicado: (2022)

Correlation Between HbA1c Levels and Mortality Rates in Hospitalized COVID-19 Patients
por: Bhagat, Ankur, et al.
Publicado: (2022)

PSUN317 IL-3 is associated with HbA1c and Serum Lipids in African Americans
por: Wamble, Ezekial, et al.
Publicado: (2022)

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children – economic evaluation
por: Petkova, Elina, et al.
Publicado: (2013)

Cross-sectional comparison of point-of-care with laboratory HbA(1c) in detecting diabetes in real-world remote Aboriginal settings
por: Marley, Julia V, et al.
Publicado: (2015)

THU322 Lower HbA1c Is Associated With Lower In-Hospital Mortality In Patients With COVID-19
por: Tsikala Vafea, Maria, et al.
Publicado: (2023)

Efficacy of Alternative Medicine in Reducing Hemoglobin A1c (HbA1c) in Type 2 Diabetes Mellitus
por: Kumar, Sagar, et al.
Publicado: (2020)

Glycated haemoglobin A(1c) (HbA(1c)) for detection of diabetes mellitus and impaired fasting glucose in Malawi: a diagnostic accuracy study
por: Rathod, Sujit D, et al.
Publicado: (2018)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
por: Chiang, Jason I, et al.
Publicado: (2020)

Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
por: Senn, Jon-Duri, et al.
Publicado: (2019)

MON-153 Spurious High HbA1c: Do We Need to Review the Guidelines?
por: Eid, Hatem
Publicado: (2019)

MON-LB025 An Artificially Low HbA1c as a Result of Dapsone Therapy
por: George, Robert, et al.
Publicado: (2019)

Point-of-care HbA(1c) testing in an urban primary care diabetes clinic in South Africa: a mixed methods feasibility study
por: Hirst, Jennifer A, et al.
Publicado: (2021)

Concordance between fasting plasma glucose and HbA(1c) in the diagnosis of diabetes in black South African adults: a cross-sectional study
por: Wade, Alisha N, et al.
Publicado: (2021)

MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
por: Owens, Lindsey L, et al.
Publicado: (2020)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

ODP163 Association of HbA1c and Comfort with Diabetes Self-Management Among Adolescents and Young Adults with Type 1 Diabetes
por: Onwukwe, Obichi, et al.
Publicado: (2022)

THU266 Lowered HbA1c In Individuals With Long-term Type 1 Diabetes Undergoing BCG Bladder Cancer Therapy
por: Dias, Hans, et al.
Publicado: (2023)

Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study
por: Choo, Monica, et al.
Publicado: (2020)

ODP237 Relation Between Long Term Glycemic Variability (LTGV) and HbA1c Time-In-Range in Diabetic Patients.
por: Delgado-Vazquez, Angel Jesus, et al.
Publicado: (2022)

PSUN300 The sex-specific correlation of IL7, high HbA1c and liver damage markers in African Americans
por: Webb, Kenisha, et al.
Publicado: (2022)

Association of Elevated Glycated Hemoglobin (HbA1c) in COVID-19 Patients Admitted to the Intensive Care Unit and Their Clinical Outcomes
por: Cuevas Velazquez, Adan M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f44unp9bvrr3ncj2aprrn57gms